Aerovate Therapeutics Inc’s recent filing unveils that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $1.55 million
Aerovate Therapeutics Inc’s recently made public that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $1.55 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Aerovate Therapeutics
Aerovate Therapeutics Inc’s recent filing unveils that its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $1.55 million
